Corporate Profile
Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The company is focused on advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and commercialization to address serious autoantibody-driven conditions worldwide.
Stock Quote
Symbol :